Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Testing the Re-Engineered Hospital Discharge

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Brian Jack, Boston University
ClinicalTrials.gov Identifier:
NCT00252057
First received: November 10, 2005
Last updated: February 27, 2017
Last verified: February 2017
Results First Received: February 10, 2009  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Outcomes Assessor;   Primary Purpose: Prevention
Condition: All
Intervention: Behavioral: Re-Engineered Hospital Discharge

  Participant Flow


  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Re-engineered Hospital Discharge Participants received the "Re-Engineered Hospital Discharge", a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist.
Standard Hospital Discharge Participants received the routine, standard hospital discharge.
Total Total of all reporting groups

Baseline Measures
   Re-engineered Hospital Discharge   Standard Hospital Discharge   Total 
Overall Participants Analyzed 
[Units: Participants]
 373   376   749 
Age 
[Units: Participants]
Count of Participants
     
<=18 years      0   0.0%      0   0.0%      0   0.0% 
Between 18 and 65 years      312  83.6%      314  83.5%      626  83.6% 
>=65 years      61  16.4%      62  16.5%      123  16.4% 
Age 
[Units: Years]
Mean (Standard Deviation)
 50.1  (15.1)   49.6  (15.3)   49.9  (15.2) 
Sex: Female, Male 
[Units: Participants]
Count of Participants
     
Female      178  47.7%      199  52.9%      377  50.3% 
Male      195  52.3%      177  47.1%      372  49.7% 
Region of Enrollment 
[Units: Participants]
     
United States   373   376   749 


  Outcome Measures

1.  Primary:   Total Number of Rehospitalizations (Emergency Department Visits Plus Hospital Admissions) in the 30 Days After Discharge.   [ Time Frame: 30 days after discharge ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information